Endocrinopathies and related with COPD exacerbation Source: Annual Congress 2012 - COPD comorbidities II Year: 2012
Are comorbidities related to frequent severe exacerbations of COPD? Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019
Static hyperinflation and respiratory disability were associated with frequent-exacerbation phenotype in patients with severe COPD Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016
Factors associated with frequent exacerbations in patients with severe asthma Source: Eur Respir J 2001; 18: Suppl. 33, 369s Year: 2001
Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history. Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021
Are COPD exacerbations associated with the severity of the disease? Source: Eur Respir J 2005; 26: Suppl. 49, 300s Year: 2005
Markers of systemic inflammation are associated with increased symptoms and respiratory exacerbations among smokers with preserved spirometry in SPIROMICS Source: International Congress 2018 – Biomarkers in COPD and asthma Year: 2018
Severe exacerbations of COPD are associated with progressive myocardial damage Source: ERS Research Seminar 2017 – Precision medicine in airway diseases Year: 2017
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013
Spirometry quality in patients with COPD exacerbation, related to the “frequent exacerbator” phenotype Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function Year: 2013
frequent exacerbations of COPD are associated with severity of airflow limitation and chronic cough, sputum production. Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019
Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD Source: Eur Respir J 2013; 41: 993-995 Year: 2013
Increased interferon and decreased NRF2-PPARG signaling is associated with frequent exacerbations in COPD Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015
A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD Source: Eur Respir J, 57 (3) 2002050; 10.1183/13993003.02050-2020 Year: 2021
Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020
Symptoms, functional parameters and exercise capacity in COPD patients with frequent and with infrequent exacerbations Source: Eur Respir J 2003; 22: Suppl. 45, 406s Year: 2003
Self-medication at exacerbation of chronic obstructive pulmonary disease (COPD) is associated with faster recovery time Source: Eur Respir J 2003; 22: Suppl. 45, 559s Year: 2003
Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013
Predicting frequent exacerbations in a severe asthma centre. Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020
Clinical determinants of exacerbations in severe, early-onset COPD Source: Eur Respir J 2007; 30: 1124-1130 Year: 2007